Australia markets closed

Agile Therapeutics, Inc. (AGRX)

OTC Markets OTCPK - OTC Markets OTCPK Delayed price. Currency in USD
Add to watchlist
0.37490.0000 (0.00%)
At close: 02:32PM EDT
Show:
Balance sheet
Cash flow
Annual

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2023
31/12/2022
31/12/2021
31/12/2020
31/12/2019
Total revenue
21,496
19,593
10,884
4,101
749
-
Cost of revenue
8,655
8,978
6,836
10,718
282
-
Gross profit
12,841
10,615
4,048
-6,617
467
-
Operating expenses
Research development
1,957
2,225
3,253
6,246
13,500
-
Selling general and administrative
26,817
28,274
42,229
58,142
36,020
-
Total operating expenses
28,774
30,499
45,482
64,388
49,520
-
Operating income or loss
-15,933
-19,884
-41,434
-71,005
-49,053
-
Interest expense
1,202
1,419
3,131
3,914
3,109
-
Total other income/expenses net
9,276
6,760
14,398
3,827
-
-
Income before tax
-7,791
-14,465
-30,087
-71,067
-51,853
-
Income tax expense
0
0
-4,675
0
0
-
Income from continuing operations
-7,791
-14,465
-25,412
-71,067
-51,853
-
Net income
-7,791
-14,465
-25,412
-71,067
-51,853
-
Net income available to common shareholders
-7,791
-14,465
-25,412
-71,067
-51,853
-
Basic EPS
7.31
-
-58.79
-1.46k
-1.22k
-760.00
Diluted EPS
7.31
-
-58.79
-1.46k
-1.22k
-760.00
Basic average shares
1,621
-
432.219
48.536
42.341
24.716
Diluted average shares
1,621
-
432.219
48.536
42.341
24.716